Hiroki Komatsuda

Immunomodulation via FGFR inhibition augments FGFR1 targeting T-cell based antitumor immunotherapy for head and neck squamous cell carcinoma

Michihisa Kono, Hiroki Komatsuda, Hidekiyo Yamaki et al. · OncoImmunology · 2022 · 34 citations · Full text

Life Sciences, Immunology, Oncology +17

Interruption of MDM2 signaling augments MDM2-targeted T cell-based antitumor immunotherapy through antigen-presenting machinery

Michihisa Kono, Takumi Kumai, Ryusuke Hayashi et al. · Cancer Immunology Immunotherapy · 2021 · 19 citations · Full text

Life Sciences, Immunology, Oncology +12

Effects of early nutritional intervention by a nutritional support team for patients with head and neck cancer undergoing chemoradiotherapy or radiotherapy

Michihisa Kono, Risa Wakisaka, Takumi Kumai et al. · Head & Neck · 2020 · 18 citations

Medicine, Nutrition, Oncology +17

Celecoxib promotes the efficacy of <scp>STING</scp>‐targeted therapy by increasing antitumor <scp>CD8</scp>⁺ T‐cell functions via modulating glucose metabolism of <scp>CD11b</scp>⁺<scp>Ly6G</scp>⁺ cells

Akemi Kosaka, Yuki Yajima, Shunsuke Yasuda et al. · International Journal of Cancer · 2022 · 14 citations

Medicine, Oncology, Pharmacology +16

IL-2 complex recovers steroid-induced inhibition in immunochemotherapy for head and neck cancer

Michihisa Kono, Hidekiyo Yamaki, Hiroki Komatsuda et al. · Translational Oncology · 2022 · 12 citations · Full text

Life Sciences, Immunology, Oncology +17